Subscribe
27 February 2025FeaturesUnified Patent CourtWouter Pors

Abbott v Sibio: A game-changer for UPC tech disputes

The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Why Abbott’s victory marks a turning point for UPC preliminary injunctions
25 February 2025   The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function claims, increasing the risk for infringers even if they modify products. Marisa Woutersen unpacks the debate over the UPC’s flexible approach to added matter and the urgency criteria.


Editor's picks

Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

Editor's picks

Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025
Americas
Regeneron holds off copies of $6bn eye treatment
4 February 2025
Careers
Bristows appoints Irish patent attorney to boost UPC representation
4 February 2025
Americas
New national rankings recognise top US patent firms and lawyers
4 February 2025
Europe
UK court upholds EU SPC precedent, rejecting MSD’s appeal
30 January 2025
Americas
ADCs, TCR, and multimodal AI: Transformative trends in 2025
23 January 2025

More on this story

Europe
Why Abbott’s victory marks a turning point for UPC preliminary injunctions
25 February 2025   The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function claims, increasing the risk for infringers even if they modify products. Marisa Woutersen unpacks the debate over the UPC’s flexible approach to added matter and the urgency criteria.

More on this story

Europe
Why Abbott’s victory marks a turning point for UPC preliminary injunctions
25 February 2025   The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function claims, increasing the risk for infringers even if they modify products. Marisa Woutersen unpacks the debate over the UPC’s flexible approach to added matter and the urgency criteria.

More features

The rise of weight loss drugs: Regulators tighten up
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
Why Abbott’s victory marks a turning point for UPC preliminary injunctions
Fed Circ’s Wuhan v ITC ruling opens ITC door to small corps
Hikma warns SCOTUS of ‘imminent threat’ for generic competition under ‘skinny label’ rules
Apple voids Omni MedSci wearable tech patent
Clifford Chance expands life sciences team with A&O Shearman hire
'A very good decision’: Patent industry welcomes UPC in-house reps update